1. Home
  2. MNOV vs LEE Comparison

MNOV vs LEE Comparison

Compare MNOV & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
    SELLHOLDBUYas of 8 hours ago
  • LEE
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • MNOV 2000
  • LEE 1890
  • Country
  • MNOV United States
  • LEE United States
  • Employees
  • MNOV N/A
  • LEE N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • MNOV Health Care
  • LEE Consumer Discretionary
  • Exchange
  • MNOV Nasdaq
  • LEE Nasdaq
  • Market Cap
  • MNOV 87.5M
  • LEE 90.6M
  • IPO Year
  • MNOV 2005
  • LEE N/A
  • Fundamental
  • Price
  • MNOV $1.47
  • LEE $8.40
  • Analyst Decision
  • MNOV Strong Buy
  • LEE
  • Analyst Count
  • MNOV 1
  • LEE 0
  • Target Price
  • MNOV $9.00
  • LEE N/A
  • AVG Volume (30 Days)
  • MNOV 18.3K
  • LEE 16.6K
  • Earning Date
  • MNOV 05-08-2025
  • LEE 05-01-2025
  • Dividend Yield
  • MNOV N/A
  • LEE N/A
  • EPS Growth
  • MNOV N/A
  • LEE N/A
  • EPS
  • MNOV N/A
  • LEE N/A
  • Revenue
  • MNOV N/A
  • LEE $600,264,000.00
  • Revenue This Year
  • MNOV N/A
  • LEE N/A
  • Revenue Next Year
  • MNOV N/A
  • LEE N/A
  • P/E Ratio
  • MNOV N/A
  • LEE N/A
  • Revenue Growth
  • MNOV N/A
  • LEE N/A
  • 52 Week Low
  • MNOV $1.12
  • LEE $7.57
  • 52 Week High
  • MNOV $2.55
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 29.19
  • LEE 29.63
  • Support Level
  • MNOV $1.45
  • LEE $9.24
  • Resistance Level
  • MNOV $1.66
  • LEE $8.90
  • Average True Range (ATR)
  • MNOV 0.07
  • LEE 0.52
  • MACD
  • MNOV -0.02
  • LEE 0.03
  • Stochastic Oscillator
  • MNOV 5.00
  • LEE 10.27

Stock Price Comparison Chart: MNOV vs LEE

MNOV
LEE
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045MNOV VS LEE

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use